BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient
Metrics: PDF 1368 views | HTML 1795 views | ?
Myriam Dao1,2, Adrien Pécriaux1, Thomas Bessede2,3, Antoine Dürrbach2,4, Charlotte Mussini1, Catherine Guettier1,2 and Sophie Ferlicot1,2
1Pathology Department, CHU Bicêtre, Le Kremlin-Bicêtre, France
2University Paris-Sud, Le Kremlin-Bicêtre, France
3Urology Department, CHU Bicêtre, Le Kremlin-Bicêtre, France
4Nephrology Department, CHU Bicêtre, Le Kremlin-Bicêtre, France
Myriam Dao, email: [email protected]
Keywords: collecting duct carcinoma; renal allograft carcinoma; kidney transplantation; BK polyomavirus; SV40
Received: November 06, 2017 Accepted: February 10, 2018 Epub: February 22, 2018 Published: March 13, 2018
BK polyomavirus (BKV) nephropathy is a major concern in renal transplantation. Its main consequence is graft loss, which occurs in more than 50% of the cases. De novo renal cell carcinoma in renal allograft is a very rare event. Most of these tumors are papillary or clear cell carcinomas. We report herein the first case of collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft adult recipient. Collecting duct carcinoma occurs long after the cure of a BKV nephropathy. At this time, BKV viremia and viruria were negative as well as the immunostaining for SV40 in the non-tumor kidney. The viral oncoprotein Tag persists only in the tumor cells. To preserve pancreas graft function, we maintained immunosuppression levels. After a 9-months follow-up, the evolution was free from clinical and radiological progression. The oncogenic role of BKV remains controversial in human cancers. However, strong experimental data have shown an association between BKV infection and urologic neoplasms. Further works might precise the exact role of polyomaviruses in renal carcinogenesis. In the meantime, clinical vigilance for early diagnostic of these tumors is mandatory after BKV nephropathy.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.